Objective: To assess the association between soyfood intake and risk of glycosuria. Design and methods: A cross-sectional study was conducted among participants of the Shanghai Women's Health Study, a population-based cohort study of women aged 40-70 y. Information on usual intake of soyfoods was obtained at baseline survey through an in-person interview using a validated food-frequency questionnaire. Included in this study were 39,385 cohort members screened for diabetes at the baseline survey and free of previously diagnosed diabetes, cardiovascular diseases, kidney diseases, and cancer. There were 323 women who tested positive for urine glucose. Odds ratios (ORs) and 95% confidence intervals (CIs) were employed to measure the association between soyfood intake and glycosuria using unconditional logistic regression. Setting: Urban communities of Shanghai, China. Results: Overall, soyfood intake was not related to the risk of glycosuria. Among postmenopausal women, however, intake of tofu and other soy products was inversely associated with risk of glycosuria after adjustment for potential confounders. The ORs across quintiles of intake were 1.0, 0.75 (95% CI ¼ 0.47-1.20), 0.79 (95% CI ¼ 0.51-1.25), 0.53 (95% CI ¼ 0.32-0.88), and 0.51 (95% CI ¼ 0.26-0.98; P for trend ¼ 0.05). Further analyses showed that the inverse association was primarily confined to postmenopausal women with a body mass index (BMI) of o25 kg/m 2 . The adjusted OR comparing the extreme quintiles was 0.36 (95% CI ¼ 0.13-0.97; P for trend ¼ 0.004). Conclusions: Soyfoods may play a role in the development of glycosuria, an important indicator of diabetes, among postmenopausal women with a low BMI.
Introduction
Soybean, a member of the legume family, is a rich source of plant protein, fiber, vitamins, minerals, and phytoestrogens (isoflavones) (Chester, 2001) . These unique components of soy have shown to have beneficial effects on glucose and insulin homeostasis. Animal studies have demonstrated that soy protein and soy isoflavones improve glycemic control, lower insulin requirement, and increase insulin sensitivity (Vahouny et al, 1985; Iritani et al, 1997; Wagner et al, 1997; Lavigne et al, 2000) . Similar benefits have also been documented in several intervention studies with soy supplements (soy protein, soy fiber, and soy isoflavones), but results have been inconsistent (Mahalko et al, 1984; Lo et al, 1986; Hermansen et al, 2001; Jayagopal et al, 2002) . One cross-sectional study has examined the effect of usual dietary intake of isoflavones on glucose metabolism and observed an inverse association with insulin level (Goodman-Gruen & Kritz-Silverstein, 2001 ). To our knowledge, no study has investigated usual consumption of soyfoods in relation to the risk of diabetes mellitus, a major public health problem.
We took advantage of the comprehensive data collected in the Shanghai Women's Health Study, a large cohort study conducted in a population with a high soyfood intake, to examine the cross-sectional association between soyfood intake and risk of glycosuria, a valuable indicator of diabetes mellitus (Ekblond et al, 2000) .
Study subjects and methods
The Shanghai Women's Health Study The Shanghai Women's Health Study (SWHS) is a population-based cohort study conducted among Chinese women in urban Shanghai. Eligible participants (n ¼ 81 271) were 40-70 y old, permanent residents of Shanghai residing in seven communities. Of them, 75 322 women (92.7%) completed the baseline survey during 1997-2000 and were recruited to the study. After exclusion of 278 women who were later found to be younger than 40 or older than 70 y at the time of the baseline interview, 75 044 women remained for the SWHS. The major reasons for nonresponse were refusal (3.0%), out of area during the baseline recruitment period (2.6%), and other miscellaneous reasons (1.8%) related to poor health conditions or communication problems.
Baseline survey
At enrollment, an in-person interview was conducted to obtain information on demographic and socioeconomic features, usual dietary intake during the past 12 months, tobacco and alcohol use, physical activity, menstrual and reproductive history, lifetime occupational history, as well as medical history, including diabetes, coronary heart disease, stroke, hypertension, and other chronic diseases ever diagnosed by a physician, along with selected medicine use, including postmenopausal hormone use. Anthropometric measurements, including weight, height, and circumferences of waist and hip in a standing position, were performed for all study participants according to a standard protocol. A 10-ml blood and spot urine samples were collected and stored at À701C for future molecular epidemiological studies.
Dietary assessment
Usual dietary intake was assessed through an in-person interview using a validated food-frequency questionnaire (FFQ). The reference period for the questionnaire was the preceding 12 months. The FFQ included 11 soyfood items covering virtually all soyfoods consumed in urban Shanghai, including tofu, soy milk, fried bean curd, bean curd cake, and other kinds of soy products. Fresh and dried soybeans were also included. For each food item, subjects were first asked to report how frequently (daily, weekly, monthly, yearly, or never) they consumed the food and followed by a question on the amount of intake in lians (50 g/lian). For seasonal foods (eg fresh legumes), in-season consumption pattern was inquired and the averaged daily consumption over a 12-month period was calculated by adjusting for the estimated months this food was consumed during the year (Shu et al, 2003) . Total soyfood consumption was estimated by summing the soy protein of each specific soyfood on the basis of the Chinese Food Composition Table (Chinese  Academy of Medical Sciences, 1991) .
A detailed description of the validity and reproducibility of the FFQ has been reported elsewhere (Shu et al, 2003) . In a random sample of 200 SWHS participants, the estimate of dietary intake derived from the FFQ was compared with that derived from 24-h dietary recalls conducted twice a month over a 12-month period. The Pearson correlation coefficient for soyfood intake was 0.49. The coefficients for nutrient intakes ranged from 0.41 to 0.64 (Shu et al, 2003) .
Urine glucose test and population for the present study A dipstick semiquantitative assay for random urinary glucose was conducted for 57 031 SWHS participants (76%) who gave a spot urine sample at the baseline survey. Of these women, 39 385 who reported no prior history of diabetes, hypertension, coronary heart disease, stroke, kidney diseases, or cancer were included in the present analysis. A cutoff point of greater than trace for urine glucose was used to define glycosuria (positive) in this study. There were 323 women who tested positive for urine glucose and were defined as cases of glycosuria. Those who tested negative for urine glucose were defined as controls.
Statistical analysis
Study participants were divided into five categories according to quintile distribution of total soy protein intake (an equivalence of total soyfood intake) among the entire cohort. The lowest quintile was treated as the reference group. Unconditional logistic regression was used to obtain maximum likelihood estimates of the odds ratios (ORs) and their 95% confidence intervals (CIs) to measure the association between soyfood consumption and glycosuria. Variables adjusted for multiple regression models included age, education, regular physical activity during the past 5 y, body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters), time interval between the last meal and urine sample collection, season of recruitment, as well as intakes of total calorie, carbohydrate, fat, nonsoy protein, and nonsoy dietary fiber. Separate analyses were conducted for tofu and other soy products that accounted for over 82% of total soy protein intake in this population.
We also conducted analyses stratified by menopausal status (menopause was defined as cessation of menstrual period not due to either pregnancy or nursing for at least 12 months) and further by BMI to explore their potential influence on the association of soy with glycosuria. Tests for linear trends were performed by using median intake value for each category and modeling them as continuous variables. Tests for interaction were performed by introducing a multiplicative interaction term into models. All statistical tests were based on two-sided probability using SAS, version 8.01 (SAS Institute, Cary, NC, USA).
Results
Distributions of demographic characteristics and selected factors that have been previously linked to type 2 diabetes are presented in Table 1 . Cases were older than controls with a mean age of 54.7 y (standard deviation (s.d.) ¼ 9.0 y) vs 50.0 (s.d. ¼ 8.4). Compared to controls, cases tended to be less educated, and have less physical activity, a higher BMI, and caloric intake. Cases were also less likely to have postmenopausal hormone replacement therapy (HRT). Age, education, physical activity, BMI, and total caloric intake were found to be significant predictors of glycosuria. No significant associations were observed with cigarette smoking, alcohol consumption, and menopausal status. Table 2 compares the selected characteristics of study participants according to quintiles of total soy protein intake. A higher intake of soyfoods was more common among older and postmenopausal women. Women with higher soy consumption also tended to have a higher level of education, a higher BMI and total caloric intake, and were more likely to drink alcohol, but less likely to smoke cigarettes. Variables related to both glycosuria risk and soy consumption, as shown in Tables 1 and 2 , were adjusted for subsequent analyses.
Overall, there was no statistically significant association between risk of glycosuria and intake of total soyfoods or tofu and other soy products after adjusting for potential confounding variables (Table 3 ). The association, however, differed markedly with menopausal status. Among postmenopausal women, intake of tofu and other soy products was significantly inversely associated with risk of glycosuria after adjusting for age, education, BMI, physical activity, time interval between last meal and urine sample collection, season of recruitment, HRT, total caloric intake and other dietary factors (P for trend ¼ 0.05). The fully adjusted OR between the lowest and highest quintiles of intake of tofu and other soy products was 0.51 (95% CI ¼ 0.26-0.98). There was no association observed for premenopausal women. Formal statistical test for interaction was significant (P ¼ 0.02).
In further analyses stratified by menopausal status and BMI, we found that the inverse association of soy product intake with glycosuria was primarily confined to postmenopausal women with a lower BMI (o25 kg/m 2 ) ( Table 4 ). The fully adjusted OR for the highest vs the lowest intake was 0.36 (95% CI ¼ 0.13-0.97; P for trend ¼ 0.004). a ORs were estimated using unconditional logistic regression and adjusted for time interval between the last meal and sample collection (1, 2-3, 4-7, and X8 h), and BMI (continuous). b Additionally adjusted for age (continuous). c Adjusted for age and time interval between the last meal and sample collection. d Additionally adjusted for age and age 2 . In all, 11 subjects with unknown menopausal status were excluded. e Hormone replacement therapy used among postmenopausal women. f Categorized by quintile distribution. Q1 denotes the first quintile; Q2-Q4, the second to fourth quintiles; Q5, the fifth quintile.
Discussion
In this large cross-sectional study of Chinese women, we found that a higher intake of soyfoods was linked to a lower risk of glycosuria among postmenopausal women with a low BMI. To our knowledge, this is the first population-based study assessing the relation between regular soyfood intake In all, 11 subjects with unknown menopausal status were excluded. b ORs were compared to the lowest quintile of intake and adjusted for age (continuous), education (four levels), regular physical activity during the past 5 y (yes/no), BMI (continuous), time interval between last meal and urine sample collection (p1, 2-3, 4-7, X8 h), season of recruitment (four categories), and dietary factors (continuous), including intakes of total calories and nonsoy dietary fiber, and intakes of carbohydrate, fat and nonsoy protein per 1000 kcal, using unconditional logistic regression. Additionally adjusted for HRT use. d Soyfood intake was converted to soy protein equivalence (soy milk, 1.8%; tofu, 8.1%; soy products other than tofu, 18.6%; soy bean, 35.1%; soy sprouts, 4.5; fresh soy bean, 13.1). Quintile cutoffs are 4. 09, 6.42, 8.96 and 12 .61 g/day for total soyfoods; and 2.35, 3.81, 5.95 and 8.94 g/day for tofu and other soy products.
and risk of glycosuria, a strong predictor of diabetes, and suggests a potential role for soyfoods in the prevention of diabetes.
A high intake of legumes has been associated with a decreased risk of type 2 diabetes in a 20-y follow-up survey from the Finnish and Dutch cohorts of the Seven Countries Study (Feskens et al, 1995) . Although no previous study has evaluated regular consumption of soyfoods (one member of the legume family) in relation to the risk of diabetes, our findings are supported by the existing evidence from animal and human studies showing that several major components of soyfoods have beneficial effects on glucose and insulin homeostasis. Animal studies have revealed that feeding soy protein results in elevated glucose disposal rates, decreased pancreatic insulin release, increased hepatic insulin removal (Vahouny et al, 1985; Lavigne et al, 2000) , and increased mRNA expressions of insulin receptors in liver and adipose tissues (Iritani et al, 1997) , suggesting some potential means by which soy may improve insulin resistance.
As suggested in previous studies, some of the soy's effects may be influenced by menopausal status and obesity (Jayagopal et al, 2002) . Our study indicated that the potential benefit from consuming tofu and other soy products was primarily confined to postmenopausal women with a low BMI. It has been shown that loss of sex hormones at menopause is associated with reduced insulin sensitivity (Proudler et al, 1992; Walton et al, 1993) , while the increased insulin resistance is ameliorated among those using HRT at a relatively low dose (Palin et al, 2001) . Phytoestrogens are similar to estrogens in molecular structure and exert weakly estrogenic action under endogenous estrogen-depleted circumstances (Adlercreutz & Mazur, 1997; Bhathena & Velasquez, 2002) . Among postmenopausal women, both dietary isoflavone intake and intake of isoflavone supplements have been associated with improved insulin resistance (Goodman-Gruen & Kritz-Silverstein, 2001; Jayagopal et al, 2002) . In addition, soy consumption in postmenopausal women has also been shown to increase sex hormonebinding globulin level (Pino et al, 2000) , which is inversely associated with impaired glucose tolerance and type 2 diabetes (Goodman-Gruen & Barrett-Connor, 1997).
The primary concern of this study is the accuracy of the method used to detect urine glucose. A recently published study, however, has demonstrated that the dipstick assay for urine glucose is quite accurate, showing a very good agreement with the quantitative estimation (k coefficient ¼ 0.8) (Chaturvedi et al, 2001) . The possibility of other sources of bias is minimized because of the population-based study design with a high participation rate and the use of validated FFQ.
Although as with any epidemiologic studies, we could not fully rule out the possibility of residual confounding, the comprehensive data collected in this study allowed us to adjust for many important factors that may confound the association of soyfoods with glycosuria.
Owing to the inherent limitations of a cross-sectional study design, the temporal sequence of soyfood intake and development of glycosuria cannot be firmly established in this study. However, we excluded those with a prior history of diabetes, hypertension, coronary heart disease, stroke, kidney diseases, or cancer and thus minimized the possibility that intake of soyfoods could be the cause of these conditions, which could have influences on glycosuria.
Our study is limited by use of glycosuria as a surrogate for diabetes. Although glycosuria is a powerful predictor of diabetes, its value in diagnosis of diabetes has been doubted. We therefore re-examined the observed association using confirmed type 2 diabetes as cases (according to the World Health Organization diagnostic criteria) (n ¼ 147) and found similar results (the corresponding OR ¼ 0.46, 95% CI ¼ 0.23-0.94; P for trend ¼ 0.03). ORs were compared to the lowest quintile of intake and adjusted for all the covariates as defined in Table 3 . b In all, 11 subjects with unknown menopausal status were excluded.
c Additionally adjusted for HRT. d See Table 2 footnote for conversion of soyfood intake to soy protein equivalence and quintile cutoffs of soyfood intake. Q1 denotes the lowest quintile; Q2-Q4, from the second to fourth quintiles; Q5, the highest quintile.
In summary, regular soyfood intake was significantly inversely associated with the risk of glycosuria among postmenopausal women with a low BMI in this large population-based study, suggesting a potential protective effect of soyfoods in the prevention of diabetes.
